Clinical Trial Update: Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of venetoclax for relapsed or refractory chronic lymphocytic leukemia is currently recruiting, with a focus on early clonal dynamics duri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Venclexto (Venetoclax)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: RECRUITING